Microbiome

The Microbiome concept focuses on the study and application of microbial communities in the human body and environment. Its core areas include probiotics, gut health, precision medicine, diagnostics, nutrition, and microbiome-based therapeutics.The sector's total market cap is 11855.90 billion KRW, with a 24h change of +2.94%. Among 5 constituents, 5 are up (100.00%) and 0 are down (0%). The top gainer is Eubiologics (206650), with a 24h increase of +5.37%.Broad weakness and lack of leadership signal a risk-off tone. Near term, stay selective and avoid chasing; favor cash‑rich, late‑stage assets, adding on pullbacks around clear regulatory or data catalysts.
Name
Last Price
Change %
Last Price / Change %
Chart
Price Range
Action
090430
Amorepacific090430
⁦K129,600.00⁩$97.03
+2.69%+$2.55
⁦K129,600.00⁩
+2.69%
$95.09$97.03
051900
LG Household & Health Care051900
⁦K235,500.00⁩$176.32
+3.51%+$5.99
⁦K235,500.00⁩
+3.51%
$170.90$176.70
206650
Eubiologics206650
⁦K8,430.00⁩$6.31
+5.37%+$0.32
⁦K8,430.00⁩
+5.37%
$6.27$6.53
376270
HEM Pharma376270
⁦K21,550.00⁩$16.13
+0.23%+$0.04
⁦K21,550.00⁩
+0.23%
$15.99$16.66
024720
Kolmar Holdings024720
⁦K8,350.00⁩$6.25
+1.21%+$0.07
⁦K8,350.00⁩
+1.21%
$6.15$6.28